Geoffrey von Maltzahn is a General Partner at Flagship Pioneering, which he joined in 2009, and Flagship describes him as an inventor, entrepreneur, CEO and co-founder of multiple companies that integrate biology and data science. Through Flagship Labs he co-founded Lila Sciences, Quotient Therapeutics, Tessera Therapeutics, Generate:Biomedicines, Indigo Agriculture, Sana Biotechnology and Seres Therapeutics. He is currently chief executive officer and a board member of Lila Sciences, board chair of Tessera Therapeutics, and chief innovation officer and a director of Indigo Agriculture. He holds a Ph.D. in biomedical engineering and medical physics from MIT and previously served as chief technology officer of Seres Therapeutics.
Education
Ph.D. Biomedical Engineering and Medical Physics, Massachusetts Institute of Technology
M.S. Bioengineering, University of California, San Diego
S.B. Chemical Engineering, Massachusetts Institute of Technology
Previous Experience
Founding CEO, Tessera Therapeutics
Founding CEO, Cobalt Biomedicine (merged with Sana Biotechnology in February 2019)